Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

EFAVIRENZ

EFAVIRENZ

Standard Dose
200MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: None (Tentative Approval)
Summary

Approval overview EFAVIRENZ is listed in Drugs@FDA under application 202042 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient EFAVIRENZ Form and strength CAPSULE; ORAL - 200MG Sponsor MICRO LABS LTD Submission history Latest submission status date: 2012-01-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview EFAVIRENZ is listed in Drugs@FDA under application 202042 (ANDA). Marketing status: None (Tentative Approval) Active ingredient EFAVIRENZ Form and strength CAPSULE; ORAL - 200MG Sponsor MICRO LABS LTD Submission history Latest submission status date: 2012-01-19 00:00:00. Submission type: ORIG.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: None (Tentative Approval)

Interaction Notes

  • No interaction notes stored yet.